0001209191-20-009045.txt : 20200212
0001209191-20-009045.hdr.sgml : 20200212
20200212215246
ACCESSION NUMBER: 0001209191-20-009045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kurkijarvi Kalevi
CENTRAL INDEX KEY: 0001621333
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 20606722
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS ST.,
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000921299
FIBROGEN INC
FGEN
0001621333
Kurkijarvi Kalevi
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
1
0
0
0
Common Stock
2020-02-10
4
M
0
6000
18.34
A
34400
D
Common Stock
2020-02-10
4
S
0
6000
42.69
D
28400
D
Stock Option (Right to Buy)
18.34
2020-02-10
4
M
0
6000
0.00
D
2025-06-03
Common Stock
6000
6000
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $42.41 to $43.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Dorothy Pacini, Attorney-in-fact
2020-02-12